Stock ABEO ABEONA THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Abeona Therapeutics Inc.

Equities

ABEO

US00289Y2063

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
3.26 USD +2.19% Intraday chart for Abeona Therapeutics Inc. -56.94% -34.93%
Apr. 23 Sector Update: Health Care Stocks Rise Late Afternoon MT
Apr. 23 Top Midday Decliners MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $40 From $22, Maintains Overweight Rating
MT
Alliance Global Starts Abeona Therapeutics at Buy With $20 Price Target
MT
SVB Securities Adjusts Price Target on Abeona Therapeutics to $5 From $1, Maintains Market Perform Rating
MT
Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $22 From $15, Reiterates Overweight Rating
MT
SVB Leerink Downgrades Abeona Therapeutics to Market Perform From Outperform; Price Target is $1
MT
HC Wainwright Adjusts Abeona Therapeutics' Price Target to $4 From $5, Keeps Buy Rating
MT
ABEONA THERAPEUTICS : HC Wainwright Adjusts Price Target on Abeona Therapeutics to $5 From $8, Maintains Buy Rating
MT
ABEONA THERAPEUTICS : HC Wainwright Adjusts Abeona Therapeutics' Price Target to $8 From $11, Keeps at Buy
MT
ABEONA THERAPEUTICS : B. Riley Adjusts Price Target on Abeona Therapeutics to $3 From $2, Reiterates Buy Rating
MT
ABEONA THERAPEUTICS : Cantor Fitzgerald Upgrades Abeona Therapeutics to Overweight From Neutral; Price Target is $4
MT
ABEONA THERAPEUTICS : SVB Leerink Adjusts Abeona Therapeutics PT to $5 From $8, Maintains Outperform Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABEO Stock
  4. News Abeona Therapeutics Inc.
  5. Analyst Reco.